AngioDynamics (ANGO) Reports In-Line Q4 EPS, Offers FY20 Guidance
Tweet Send to a Friend
AngioDynamics (NASDAQ: ANGO) reported Q4 EPS of $0.25, in-line with the analyst estimate ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
